文献速递免疫规划传染病防控与疫情报告

赞比亚霍乱康复者与疫苗接种成人血清杀弧菌抗体的比较分析

Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia.
PubMed 文献 · Vaccine · 2024-05-17

本研究比较赞比亚东方省霍乱疫情期间50名自然感染者与中央省56名口服霍乱疫苗接种者的杀弧菌抗体几何平均滴度,发现完成2剂接种者第28天针对Ogawa型抗体滴度高于自然感染者(p<0.047),抗体最低出现在发病后0-9天,峰值在10-19天,作者建议感染后40天接种疫苗。

要点

  • 完成2剂口服霍乱疫苗者第28天抗Ogawa杀弧菌抗体滴度高于自然感染者(p<0.047)。
  • 自然感染后抗体最低出现在发病0-9天,峰值在10-19天。
  • 作者建议感染后40天接种疫苗以获得持久免疫和 prolonged 保护,尤其在霍乱热点地区。

核心结论

  • 接种两剂口服霍乱疫苗者抗体滴度高于自然感染者,作者认为疫苗诱导的免疫应答可能更优。
  • 作者建议感染后40天接种疫苗以获得持久免疫和 prolonged 保护,尤其在霍乱热点地区。

研究设计与样本

  • 比较性研究,纳入赞比亚东方省霍乱疫情期间50名自然感染者及赞比亚中央省56名口服霍乱疫苗接种者。

主要发现

  • 自然感染者与完成2剂疫苗接种者第28天针对霍乱弧菌Ogawa型的杀弧菌抗体比较差异显著(p<0.047)。
  • 接种两剂口服霍乱疫苗者抗体滴度高于自然感染者。
  • 抗体滴度最低出现在发病后0-9天,峰值出现在10-19天。

临床怎么用

  • 作者建议感染后40天接种疫苗以获得持久免疫和 prolonged 保护,尤其在霍乱热点地区。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cholera is responsible for 1.3 to 4.0 million cholera cases globally and poses a significant threat, with Zambia reporting 17,169 cases as of 4th February 2024. Recognizing the crucial link between natural cholera infections and vaccine protection, this study aimed to assess immune responses post cholera infection and vaccination. This was a comparative study consisting of 50 participants enrolled during a cholera outbreak in Zambia's Eastern Province and an additional 56 participants who received oral cholera vaccinations in Zambia's Central Province. Vibriocidal antibodies were plotted as geometric mean titres in the naturally infected and vaccinated individuals. A significant difference (p < 0.047) emerged when comparing naturally infected to fully vaccinated individuals (2 doses) on day 28 against V. cholerae Ogawa. Those who received two doses of the oral cholera vaccine had higher antibody titres than those who were naturally infected. Notably, the lowest titres occurred between 0-9 days post onset, contrasting with peak responses at 10-19 days. This study addresses a critical knowledge gap in understanding cholera immunity dynamics, emphasizing the potential superiority of vaccination-induced immune responses. We recommend post infection vaccination after 40 days for sustained immunity and prolonged protection, especially in cholera hotspots.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ng'ombe H, Bosomprah S, Phiri B, et al. Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia. Vaccine. 2024. PMID: 38760271. doi:10.1016/j.vaccine.2024.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。